NEPA to prevent chemotherapy-induced nausea and vomiting

Matti Aapro, MD, of Genolier Cancer Center, Genolier, Switzerland, outlines the efficacy of intravenous NEPA for the prevention of CINV following cisplatin and AC chemotherapy and whether is it a viable prevention treatment. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.